EVENTS | VIEW CALENDAR
Invitrogen gives clients ability to bag it up
CARLSBAD, Calif. – Invitrogen Corporation and Wave Biotech, LLC have announced a partnership that will offer Invitrogen's cell cultures in Wave's disposable bioreactor bags.
Invitrogen will offer Wave's flexible packaging line—pre-filled—both on-line and through its conventional customer service channel. Although Wave Biotech offers both standard and custom pre-filled bags, Invitrogen will sell both as custom, at least at first, offering "What the customer wants, when they want it," according to Nicole Brockway, business segment manager for Invitrogen cell culture systems. In the past, Invitrogen's cell culture line had been provided in bags used for delivery only.
"This partnership opens up a pathway to new customers," Brockway adds, "and provides total solutions for their cell culture needs. Prefilled bags are disposable and do not require validation, so they eliminate steps in the typical research, pilot plant, or production process. And because scalability is built-in to the technology, further economies and time savings result as products move from the lab into production."
For Wave Biotech, "Invitrogen's commitment to making its products readily accessible to our customers, and its knowledge of the specialized needs of research and bioproduction customers were key factors in our selection of Invitrogen as our partner," states Daniella Kranjac, vice president, sales and marketing.
Wave Biotech and Invitrogen are a study in contrasts, with the former focused on the line of patented disposable bioreactors developed by company founder Vijay Singh. Because key products, such as the Wave bioreactors, mixers, and sterile tube fusers feature disposable contact materials that eliminate cleaning and validation, they reduce costs in operations ranging from cell culture, media preparation, and buffer dissolution to patient-specific cell therapy in hospitals. The company notes that these unique devices can be installed and commissioned rapidly, thereby significantly reducing the time-to-market for biological products.
According to a company spokesman, Wave is "growing by leaps and bounds," which is attested to by its move from a rented 15,000 sq. ft. facility to its own 80,000 sq. ft. headquarters in late 2005. About the same time, the company established its first European site in Cork, Ireland. Though a different sort of business, Invitrogen is also growth oriented. Nicole Brockway points out that Invitrogen has acquired 16 companies over the past four years and announced "dozens and dozens" of collaborations.